Table 2.
The incidence and amount of rocuronium use during anesthetic induction and surgery.
| Group | PPF-TIVA (n = 90) | RMZ-TIVA (n = 57) | Inhalation (n = 174) | p Value |
|---|---|---|---|---|
| Total use, n (%) | 22 (24.4) | 34 (59.6) | 84 (48.3) | 0.003 |
| Dose (mg) * | 9.94 ± 19.61 | 12.59 ± 14.11 | 11.15 ± 13.88 | 0.611 |
| Anesthetic induction, n (%) | 13 (14.4) | 21 (36.8) | 57 (32.7) | 0.002 |
| (diffi. vent./self/diffi. insert./hiccup) # | (11/2/1/0) | (14/5/1/1) | (31/19/7/0) | |
| Dose (mg) * | 3.39 ± 7.93 | 7.32 ± 11.83 | 6.58 ± 10.28 | 0.023 |
| During surgery | ||||
| at start, n | 6 | 15 | 34 | |
| Dose (mg) * | 1.00 ± 4.25 | 4.46 ± 8.51 | 2.50 ± 5.29 | 0.002 |
| Thereafter, n | 6 | 7 | 24 | |
| Dose (mg) * | 0.89 ± 3.56 | 1.61 ± 4.58 | 1.81 ± 4.93 | 0.290 |
* Continuous values are shown as the mean ± standard deviation. Categorical variables are expressed as the number of patients. # diffi. vent.: difficult ventilation/self/diffi. insert.: difficult insertion/hiccup.